The Journey of a Patient with Fibrocalculous Pancreatic Diabetes from Injectable Insulins to Hybrid Closed-Loop Insulin Pump: A Case Report
Journal of Diabetology · 2026-05 · 17 (3) · 292-294
DOI: 10.4103/jod.jod_121_25 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Diabetology, online erschienen am 22.05.2026. Verfasst von Varun Damle und 1 weiteren Autor:innen. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Fibrocalculous pancreatic diabetes (FCPD) is a rare form of secondary diabetes in which there is insulin deficiency. The mainstay of treatment for FCPD is insulin. When insulin is delivered through basal bolus regime, there is a risk of hypo and hyperglycemic episodes if the dose is not adjusted properly. In this case, we report the journey of a patient with FCPD who was earlier on basal bolus insulin regime and later switched to the automated hybrid closed-loop 780G insulin pump, which significantly improved her quality of life.
Zitieren
APA
Damle, V., & Mohan, V. (2026). The Journey of a Patient with Fibrocalculous Pancreatic Diabetes from Injectable Insulins to Hybrid Closed-Loop Insulin Pump: A Case Report. Journal of Diabetology, 17(3), 292-294. https://doi.org/10.4103/jod.jod_121_25
Vancouver
Damle V, Mohan V. The Journey of a Patient with Fibrocalculous Pancreatic Diabetes from Injectable Insulins to Hybrid Closed-Loop Insulin Pump: A Case Report. Journal of Diabetology. 2026;17(3):292-294. doi:10.4103/jod.jod_121_25
BibTeX
@article{Damle2026,
author = {Damle, Varun and Mohan, Viswanathan},
title = {The Journey of a Patient with Fibrocalculous Pancreatic Diabetes from Injectable Insulins to Hybrid Closed-Loop Insulin Pump: A Case Report},
journal = {Journal of Diabetology},
year = {2026},
volume = {17},
number = {3},
pages = {292--294},
doi = {10.4103/jod.jod_121_25}
}
EUVIMED